Atlas Trials

Treatment of Older Patients With B-precursor ALL With Sequential Dose Reduced Chemotherapy and Blinatumomab

Clinical trial NCT03480438 · COMPLETED

Trial details

NCT number
NCT03480438
Sponsor
Goethe University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
B-Precursor ALL
Start date
2018-06-01
Primary completion
2024-01-10
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.